Buscar en
Endocrinología, Diabetes y Nutrición
Toda la web
Inicio Endocrinología, Diabetes y Nutrición Dietary intake and nutritional status in patients with systemic lupus erythemato...
Información de la revista
Vol. 65. Núm. 9.
Páginas 533-539 (Noviembre 2018)
Descargar PDF
Más opciones de artículo
Vol. 65. Núm. 9.
Páginas 533-539 (Noviembre 2018)
Original article
Acceso a texto completo
Dietary intake and nutritional status in patients with systemic lupus erythematosus
Ingesta dietética y estado nutricional en pacientes con lupus eritematoso sistémico
Gabriela Pocovi-Gerardinoa,b, María Correa-Rodrígueza,c,
Autor para correspondencia

Corresponding author.
, José Luis Callejas-Rubioa,d, Raquel Ríos-Fernándeza,d, Norberto Ortego-Centenoa,d, Blanca Rueda-Medinaa,c
a Instituto de Investigación Biosanitaria, IBS, Granada, Spain
b Universidad de Granada, UGR, Granada, Spain
c Faculty of Health Science, University of Granada, Spain
d Hospital Campus de la Salud, Granada, Spain
Información del artículo
Texto completo
Descargar PDF
Figuras (2)
Tablas (3)
Table 1. Mean dietary intake of energy and nutrients in SLE patients compared with Spanish population as control.
Table 2. Energy contribution of macronutrients, fiber and fat sources in lupus population and Spanish control population (ENIDE study) compared to Spanish Society of Community Nutrition (SENC) nutrition goals.
Table 3. Mean micronutrient intake in SLE patients compared with Spanish dietary reference intake (DRI).
Mostrar másMostrar menos

Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease. Despite the influence of diet on inflammation, dietary habits in patients with systemic lupus erythematosus (SLE) are not well established. The study objective was to assess dietary intake and nutritional status in SLE patients.

Patients and methods

A cross-sectional study was conducted in 92 patients with SLE. Nutritional status was determined by body mass index (BMI) and energy/nutrient distribution of diet was analyzed and compared to a control group. Dietary reference intakes (DRIs) issued by the Spanish Societies of Nutrition, Feeding and Dietetics (FESNAD) and the Spanish Society of Community Nutrition (SENC) were used as reference.


Body mass index was normal in 53.26% of patients, while 43.48% had excess weight. Energy, protein, and fat intake was significantly lower in the SLE group (p=0.003, p=0.000, and p=0.001 respectively). Protein and fat contribution to total energy was higher, while that of carbohydrate and fiber was lower than recommended. Most patients did not reach the recommended intake for iron (88%), calcium (65.2%), iodine (92.4%), potassium (73.9%), magnesium (65%), folate (72.8%), and vitamins E (87%) and D (82.6%), but exceeded the recommendations for sodium and phosphorus.


Spanish SLE patients have an unbalanced diet characterized by low carbohydrate/fiber and high protein/fat intakes. Significant deficiencies were seen in micronutrient intake. Dietary counseling to improve nutrition would therefore be advisable in management of SLE.

Systemic lupus erythematosus
Nutritional status
Dietary habits
Dietary intake
Body weight

El lupus eritematoso sistémico (LES) es una enfermedad autoinmune, crónica e inflamatoria. La dieta tiene un importante impacto en este tipo de enfermedades. Así, el objetivo de este estudio fue conocer la ingesta dietética y el estado nutricional en pacientes con LES.

Pacientes y métodos

Se realizó un estudio transversal que incluyó 92 pacientes diagnosticados de LES. Se determinó el estado nutricional y la ingesta dietética de los pacientes contrastando con un grupo control usando como referencia las recomendaciones de la Federación Española de Sociedades de Nutrición, Alimentación y Dietética (FESNAD) y la Sociedad Española de Nutrición Comunitaria (SENC).


El índice de masa corporal (IMC) fue normal en el 53,26% de los pacientes, mientras que el 43,48% se ubicó en categorías de exceso. La ingesta calórica, proteica y de grasas fue significativamente menor en el grupo con LES (p=0,003, p=0,000 y p=0,001, respectivamente). La contribución de la ingesta proteica y de grasa a la energía total fue mayor que la recomendada, mientras que la de carbohidratos y fibra, menor. La mayoría de los pacientes no alcanzaron las recomendaciones de ingesta de hierro (88%), calcio (65,2%), iodo (92,4%), potasio (73,9%), magnesio (65%), folato (72,8%), vitaminas E (87%) y D (82,6%) y excedieron las de sodio y fósforo.


La dieta de los pacientes con LES analizados no es equilibrada en el consumo de macronutrientes y fibra, observándose deficiencias en la ingesta de micronutrientes esenciales. Por lo tanto, sería aconsejable el asesoramiento dietético como parte de su tratamiento.

Palabras clave:
Lupus eritematoso sistémico
Estado nutricional
Hábitos dietéticos
Ingesta dietética
Peso corporal
Texto completo

Systemic lupus erythematosus (SLE) is a chronic disease characterized by an abnormal inflammatory and autoimmune response due to the presence of hyperactive B cells and the production of autoantibodies that, in conjunction with the impaired removal of apoptotic cellular material, results in the formation of immune complexes. These complexes induce inflammatory reactions, causing the tissue inflammation and damage associated with SLE.1

Recently, nutrition and lifestyle patterns have emerged as important factors influencing the health of individuals, including the inflammatory response. Several pieces of evidence support the fact that nutritional status influences the development and prognosis of inflammatory diseases. In this context, a diet rich in polyunsaturated fatty acids, fiber, vegetables, and fruit, combined with physical activity, has been shown to improve the quality of life of patients with rheumatoid arthritis2–4 or cancer,5,6 as well as prevent the incidence, and even slow the progression of the disease through the modulation of several inflammatory pathways.7,8

In SLE, evidence from studies of patients and animal models suggests that a balanced diet including a moderate calorie and protein content but high in vitamins, minerals (especially antioxidants), and mono/polyunsaturated fatty acids, can protect against tissue damage and suppress inflammatory activity.9 In addition, this dietary pattern prevents overweight, insulin resistance, and thus decreases the risk of developing cardiovascular disease, one of the most common complications in SLE patients.10

The nutritional status and food intake of patients with SLE may therefore influence the course of the disease. However, in most countries there is very limited knowledge on the patterns and nutritional adequacy of the diet of lupus sufferers compared to normal or healthy people. In particular, to our knowledge, this issue has not previously been addressed in Spanish SLE patients.

Considering all this evidence, the aim of this study was to assess the dietary intake and nutritional status of Spanish patients with SLE in order to determine whether they achieve a well-balanced diet and nutrient intake and estimate possible nutritional differences between this group and the general population.

Subjects and methodsStudy group

A cross-sectional study was designed, and 92 patients diagnosed with SLE were recruited in the Outpatient Clinic of the Systemic Autoimmune Diseases Unit at San Cecilio University Hospital in Granada (Spain). All the SLE patients included met the diagnostic criteria according to the American College of Rheumatology (ACR) revised classification or SLICC criteria11–13 and had been diagnosed with the disease at least one year prior to the study. Disease activity was determined using the SLEDAI-2K.14 Patients with late-stage lupus, serum creatinine ≥1.5mg/dl, diabetes mellitus, ischemic heart diseases, cerebrovascular disease, recent infections, trauma or surgery, SLICC >5, pregnancy and/or other chronic and/or autoimmune systemic conditions not related with the main disease were excluded from the study. All participants received verbal and written information on the nature and purpose of the study and gave their written consent for their participation. Ethical approval for the work was obtained from the local Ethics Committee (CEI Granada) and conducted in accordance with the Declaration of Helsinki.

Nutritional assessment

Dietary intake was assessed through a 24-h diet recall in a personal interview carried out by a trained nutritionist-dietician in which the participants were asked, meal by meal, about portions and amounts of each food consumed, the number and amount of ingredients used in each recipe, as well as questions relating to menu preparation (type of oil, milk, or cheese used) as well as sweets, alcoholic and non-alcoholic drinks, and added sugar. To improve the accuracy of the food quantities recorded, standard household measures and pictorial food models were used.

Food records were converted to nutrient intake using a computerized nutrient analysis program (Nutriber 1.1.5). Energy contribution was calculated in terms of percentage (%) of each macronutrient considering that one gram of protein or carbohydrates equals 4 kilocalories and each gram of fat equals 9 kilocalories.

Nutritional status was determined by body mass index (BMI). Patients were classified as malnourished (BMI??18.5kg/m2), normal weight (BMI 18.6–24.9kg/m2), overweight (BMI 25–29.9kg/m2), or obese (BMI30kg/m2), based on World Health Organization criteria.15

Energy and nutrient intake of lupus patients was compared to nutritional data as reference obtained from the Spanish National Dietary Intake Survey (ENIDE) carried out in 2011.16 ENIDE is a representative national-level study of food and nutrient intake in the adult population. It was based on a random selection of more than 3323 individuals, providing a 95% confidence level and an accuracy of 1.8%.16 As our study population included 92.4% women with a mean age of 44.3, data from the female population aged 18–64 years was selected as a reference to compare with the cohort of lupus sufferers.

Dietary reference intakes (DRI) for the Spanish population issued by the Spanish Societies of Nutrition Feeding and Dietetics (FESNAD),17 in 2010, and the Spanish Society of Community Nutrition (SENC)18 dietary guidelines and nutrition goals for the Spanish population19 were taken as references to interpret the 24-h food and beverage recall.

Statistical analysis

The information obtained was recorded and analyzed using the statistics program SPSS (Statistical Package for Social Science) for Windows, version 22. We described numeric variables through the median±standard deviation while qualitative or nominal variables were described through percentages and frequencies. Differences in the mean dietary intake of energy and nutrients between SLE patients and the control population were estimated with Student's or Welch's t-test. The values were considered significant when p was <0.05.


Ninety-two percent (92.3%) of the patients were female and 7.7% were male. The mean age of the study cohort was 44.47±13.45 and the mean time since being diagnosed with SLE was 7.85±4.29 years. All study participants showed a low to moderate activity of the disease (mean SLEDAI: 3.52) and very low damage index (mean SLICC: 1.27), ranging from 0 to 5.

Nutritional status according to BMI is shown in Fig. 1. Of note, 53.26% of patients were in the normal range for BMI and 43.48% were in either the overweight or obesity categories; only 3.26% of the lupus population was underweight.

Figure 1.

Nutritional status of SLE patients, according to BMI and the WHO classification criteria.


The percentage of calories, protein, total fat intake, and dietary cholesterol intake was significantly lower in lupus patients than the Spanish population data used as a control (p=0.003, p=0.000, p=0.001 and p=0.006, respectively). No significant differences were observed for other nutrients such as total carbohydrates, fiber, and fatty acid intake (Table 1).

Table 1.

Mean dietary intake of energy and nutrients in SLE patients compared with Spanish population as control.

Daily Intake (n=92)  Lupus population (n=92)  Control Spanish population (n=1734)  p 
Calories (kcal)  1879.09 (502.67)  2038.30 (655.41)  0.003 
Proteins (g)  75.52 (24.50)  88.00 (37.75)  0.000 
Carbohydrates (g)  194.68 (60.16)  199.71 (75.88)  0.424 
Dietary fiber (g)  19.51 (9.61)  18.85 (10.06)  0.509 
Total fat (g)  83.42 (28.02)  93.22 (35.59)  0.001 
Saturated fat (g)  26.99 (11.94)  25.68 (11.68)  0.296 
Monounsaturated fat (g)  37.92 (12.58)  38.79 (17.05)  0.507 
Polyunsaturated fat (g)  11.98 (5.75)  12.60 (7.47)  0.307 
(PUFA+MUFA)/SFA  2.04  0.594 
PUFA/SFA  0.49  0.49  0.953 
Cholesterol (mg)  282.79 (183.92)  336.22 (150.76)  0.006 

Notes: Values are means±SD (standard deviation).

PUFA, polyunsaturated fatty acids; MUFA, monounsaturated fatty acids; SFA, saturated fatty acids.

With regard to the energy contribution of macronutrients, similarly to the control group, protein represented 16.07% of the total energy intake for SLE patients (Table 2). Thus, protein contribution was excessive in both lupus sufferers and the general Spanish population when compared to SENC recommendations.18 Conversely, both lupus patients and the control subjects showed a pattern of low carbohydrate levels in their diets, with figures below the SENC recommendations (50–60%) (Table 2). Total fat intake was notably higher in both lupus patients (39.95%) and the control population (41.16%) compared to the SENC recommendations, which suggest a range of 30–35%. Nevertheless, monounsaturated and polyunsaturated fatty acid goals were reached in both lupus sufferers and the control population. In addition, lupus patients and the control population consumed low amounts of dietary fiber according to SENC goals (Table 2).

Table 2.

Energy contribution of macronutrients, fiber and fat sources in lupus population and Spanish control population (ENIDE study) compared to Spanish Society of Community Nutrition (SENC) nutrition goals.

Nutrient  Lupus population (n=92)  Spanish population-control (n=1734)  SENC nutrition goals 
Protein (%)  16.07  17.27  10–15 
Carbohydrates (%)  41.44  39.19  50–60 
Total fat (%)  39.95  41.16  30–35 
Saturated fat (%)  12.92  11.34  ??7–8 
Monounsaturated fat (%)  18.16  17.13  20 
Polyunsaturated fat (%)  5.73  5.56 
Dietary fiber (gr)  19.51  18.85  >25 
Cholesterol (mg)  282.79  336.22  ≤300 

Notes: Values are expressed in percentage (%) according to dietary contribution of each nutrient.

Interestingly, significant differences were seen in the vitamin and mineral intake of lupus patients compared with the Spanish population used as a control (Table 3). In lupus patients, a significantly lower intake was reported for magnesium, iron, thiamine, niacin, and vitamin E (p=0.000, p=0.017, p=0.010, p=0.000, respectively); while there was an inverse relationship for selenium, riboflavin, vitamin B12, and vitamin A (p=0.000, p=0.002, p=0.006, p=0.000, respectively) (Table 3). Both groups met the FESNAD suggested daily intake levels for thiamine, riboflavin, niacin, vitamin B12, and vitamin A, but did not achieve the recommended levels for calcium, iron, iodine, potassium, folic acid, or vitamin E. For both groups, the sodium and phosphorus intakes exceeded daily recommendations. An interesting finding was that dietary magnesium was below the FESNAD recommendations only in SLE patients.

Table 3.

Mean micronutrient intake in SLE patients compared with Spanish dietary reference intake (DRI).

Nutrient  Lupus population (n=92)  Control Spanish population (n=1734)  p  DRI FESNAD 
Calcium (mg)  820.74 (344.67)  834.76  0.697  900 
Phosphorus (mg)  1331.01 (451.21)  1294.73  0.674  700 
Iron (mg)  12.44 (4.97)  13.7  0.017  18 
Iodine (μg)  108.51 (167.75)  84.81  0.179  150 
Magnesium (mg)  267.09 (81.70)  353.84  0.000  300 
Zinc (mg)  8.91 (3.71)  8.72  0.621 
Selenium (μg)  100.58 (53.29)  53.71  0.000  55 
Sodium (mg)  2391.33 (1107.70)  2348.85  0.714  1500 
Potassium (mg)  2703.05 (944.203)  2857.78  0.119  3100 
Vitamin B1 Thiamine (mg)  1.43 (1.18)  1.76  0.010 
Vitamin B2 Riboflavin (mg)  1.70 (0.67)  1.44  0.002  1.3 
Niacin Eq. (mg)  30.38 (11.79)  39.37  0.000  14 
Vitamin B6 pyridoxine (mg)  1.76 (0.836)  1.66  0.267  1.2 
Folic acid (μg)  261.86 (141.12)  266.37  0.760  300 
Vitamin B12 (μg)  10.52 (15.07)  6.06  0.006 
Vitamin A (Retinol Eq.) (μg)  750.94 (492.69)  722.52  0.000  600 
Vitamin E (μg)  9.52 (5.38)  13.39  0.000  15 
Vitamin D (μg)  5.34 (13.39)  3.65  0.228 
Vitamin C (mg)  120.22 (79.09)  132.92  0.099  60 

Values are expressed as means±SD (standard deviation).

The vast majority of lupus patients showed a very low compliance with micronutrient intake recommendations, with iron (88%), calcium (65.2%), iodine (92.4%), potassium (73.9%), magnesium (65%), folate (72.8%), vitamin E (87%), and vitamin D (82.6%) intakes being below daily dietary recommendations, whereas sodium and phosphorus exceeded the daily suggested intakes, just as in the Spanish control population (Fig. 2).

Figure 2.

Distribution of lupus patients according to achievement of dietary reference intake of vitamins and minerals proposed by the Spanish Societies of Nutrition and Dietetics (FESNAD).


In this study, for the first time, we evaluated nutritional status and analyzed dietary intake in a well-characterized, medically stable cohort of lupus patients. The study group included a very low prevalence of undernutrition according to BMI and the WHO classification. This is probably because the participants were ambulatory and had controlled disease with no late-stage complications, appetite suppression, or weight loss. In fact, previous studies conducted on different populations of lupus patients have shown similar results, with underweight values being around 1–2%, overweight between 35.3% and 35.9%, and obesity at 27.7%–28.3%.20,21

With regard to the dietary habits of lupus sufferers, we found that they consumed significantly less amounts of energy, protein, total fat, and cholesterol compared with average intakes in the control Spanish population (ENIDE). Additionally, our data supports the finding that the diet of lupus patients and the Spanish population in general, is characterized by an imbalance in macronutrient energy contribution with a low carbohydrate, high protein/fat diet pattern together with more saturated fat and less fiber intake than SENC recommendations. To our knowledge, only two previous studies have assessed this issue in lupus patients.10,20

Elkan et al. (2012), evaluated macronutrient intake in Swedish SLE patients and reported a decreased intake of polyunsaturated fatty acids (omega-3 and omega-6) and fiber, and an increased intake of carbohydrates, compared with a control population. In another study assessing dietary habits in a Brazilian lupus cohort, a high consumption of fats and oils was reported.20 Thus, our data, when taken together with previous findings, points to the fact that there is a similar trend in lupus sufferers to that seen in the general population; SLE patients’ dietary habits are marked by a high fat – low fiber intake. Therefore, in the context of an autoimmune inflammatory disease such as SLE, it is important to consider that both fat and fiber intake can either directly or indirectly modify immune and inflammatory responses. Saturated fatty acid (SFA) intake correlates with a pro-inflammatory response upregulating several genes of inflammatory pathways, while monounsaturated fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs) exhibit an anti-inflammatory profile. Fiber intake has been inversely associated with plasma homocysteine and inflammatory markers including IL-6 and CRP (C-reactive protein).22–24 Considering this, dietary interventions to increase fiber intake to 25 grams/day, as suggested by SENC,18 PUFAs, MUFAs and decrease saturated fat consumption, should be considered to help reduce both inflammation and cardiovascular risk in lupus patients, as well as in the Spanish population.22,25–27

Another important aspect is that lupus patients presented several micronutrient deficiencies. Specifically, there were significantly low intakes of iron, magnesium, folic acid, vitamin B1, niacin and vitamin E. Our findings are in line with the study of Borges et al., conducted on a Brazilian cohort of lupus sufferers, which showed an inadequate intake of iron and vitamin B12. Interestingly, some of these micronutrients have been shown to influence the immune response.21

Magnesium deficiency seems to contribute to an exaggerated immune stress response, proatherogenic changes in lipoprotein metabolism, endothelial dysfunction, thrombosis, and hypertension, which explains the aggravating effect of magnesium deficiency on the course of inflammatory diseases.28 In addition, lower levels of serum magnesium in SLE patients compared to controls have been reported.

Another micronutrient intake level below the RDI in both lupus and the Spanish population was folic acid. Elevated homocysteine levels are common in chronic immune-mediated disorders and lead to accelerated atherosclerosis and increased cardiovascular risk.29 Folic acid is critical in determining plasma homocysteine levels.30 A very recent study showed that folate was associated with several markers of atherosclerosis and vascular disease31; however, previous studies suggest it improves cardiovascular health.32

It has also been suggested that vitamin E can regulate antibody production and suppress autoantibody production in SLE independently of its antioxidant activity.33

Thus, although further studies are required to fully elucidate the impact of these micronutrients in autoimmunity, and specifically in SLE, it might be important to implement nutritional counseling and/or supplement strategies to achieve adequate intakes levels.

We are aware that the cross-sectional design of the study limits our ability to determine causal relationships with the associations detected because it only provides the nutritional status at a specific point in time. In addition, another possible limitation of this study is the fact that the lupus patient's dietary intake was assessed using a 24-hour recall whereas the dietary intake of the ENIDE control population was estimated using both a 24-hour recall and a daily food registry over three random days. To minimize the possibility of bias in the dietary intake of our study population, the 24-hour diet recall data collection was performed in a personal interview conducted by a trained nutritionist-dietician.

In summary, our data supports the fact that diet pattern in SLE patients is characterized by low carbohydrate/fiber levels and a high protein/fat intake similar to the Spanish population. In addition, a poor micronutrient dietary intake was found for calcium, iron, iodine, magnesium, potassium, folic acid, and vitamin E in SLE patients. Considering the high risk of malnutrition, infections, osteoporosis, and cardiovascular diseases in SLE, dietary counseling to help improve nutritional habits in lupus patients should be considered an important strategy in the management of the disease.

Author's contribution

The authors have contributed equally to this work.

Pocovi-Gerardino G performed patient's nutritional assessments, analyzed and interpreted the data and wrote the manuscript. Correa-Rodríguez M analyzed the data and performed statistical analyses. Callejas-Rubio J-L and Rios-Fernandez R performed patient recruitment and clinical assessment. Ortego-Centeno N contributed to the conception and study design, patient recruitment and reviewed/edited manuscript, Rueda-Medina B contributed to the conception, study design, data interpretation and reviewed/edited manuscript.

Transparency declaration

The corresponding author on behalf of the other authors guarantee the accuracy, transparency and honesty of the data and information contained in the study, that no relevant information has been omitted and that all discrepancies between authors have been adequately resolved and described.

Acknowledgements & fundings

This study was supported by the grant PI0523-2016 from “Consejería de igualdad, salud y políticas sociales” (Junta de Andalucía). Pocovi-Gerardino G is a predoctoral fellow from the doctoral program “Medicina clínica y salud pública” of the University of Granada.

Conflict of interest

The authors declare no conflict of interest.

W. Maidhof, O. Hilas.
Lupus: an overview of the disease and management options.
P T, 37 (2012), pp. 240-249
L. Sköldstam, L. Hagfors, G. Johansson.
An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis.
Ann Rheum Dis, 62 (2003), pp. 208-214
L.G. Kim, J. Adamson, S. Ebrahim.
Influence of life-style choices on locomotor disability, arthritis and cardiovascular disease in older women: prospective cohort study.
Age Age, 42 (2013), pp. 696-701
F. Oliviero, P. Spinella, U. Fiocco, R. Ramonda, P. Sfriso, L. Punzi.
How the Mediterranean diet and some of its components modulate inflammatory pathways in arthritis.
Swiss Med Wkly, 145 (2015), pp. w14190
H.Y. Kwan, X. Chao, T. Su, X. Fu, A.K.W. Tse, W.F. Fong, et al.
The anti-cancer and anti-obesity effects of Mediterranean diet.
Crit Rev Food Sci Nutr, 57 (2015), pp. 82-94
R. Ostan, C. Lanzarini, E. Pini, M. Scurti, D. Vianello, C. Bertarelli, et al.
Inflammaging and cancer: a challenge for the Mediterranean diet.
Nutrients, 7 (2015), pp. 2589-2621
L. Schwingshackl, M. Christoph, G. Hoffmann.
Effects of olive oil on markers of inflammation and endothelial function. A systematic review and meta-analysis.
Nutrients, 7 (2015), pp. 7651-7675
R. Estruch.
Session 4: dietary strategies to prevent and mitigate inflammatory diseases Anti-inflammatory effects of the Mediterranean diet: the experience of the PREDIMED study.
K. Klack, E. Bonfa, E.F.B. Neto.
Diet and nutritional aspects in systemic lupus erythematosus.
Rev Bras Reumatol, 52 (2012), pp. 384-408
A.-C. Elkan, C. Anania, T. Gustafsson, T. Jogestrand, I. Hafstrom, J. Frostegard.
Diet and fatty acid pattern among patients with SLE: associations with disease activity, blood lipids and atherosclerosis.
Lupus, 21 (2012), pp. 1405-1411
M.C. Hochberg.
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.
E.M. Tan, A.S. Cohen, J.F. Fries, A.T. Masi, D.J. Mcshane, N.F. Rothfield, et al.
The 1982 revised criteria for the classification of systemic lupus erythrematosus.
Arthritis Rheum, 25 (1982), pp. 1271-1277
C. Yu, M.E. Gershwin, C. Chang.
Diagnostic criteria for systemic lupus erythematosus: a critical review.
J Autoimmun, 48–49 (2014), pp. 10-13
D.D. Gladman, D. Ibañez, M.B. Urowitz.
Systemic lupus erythematosus disease activity index 2000.
J Rheumatol, 29 (2002), pp. 288-291
Obesity: preventing and managing the global epidemic.
Rep WHO Consult, (2000),
La NDE, Espa D. Energía y Macronutrientes Sobre Datos de la Encuesta Nacional de Ingesta Dietética (ENIDE) s. f. 2012.
I. Diet.
Ingestas Dietéticas de Referencia (IDR) para la Población Española.
Act Diet, 14 (2010), pp. 196-197
L. Serra Majem.
Objetivos nutricionales para la población española: consenso de la Sociedad Española de Nutrición Comunitaria 2011.
Rev española Nutr comunitaria=Spanish J community Nutr, 17 (2011), pp. 178-199
Ingestas Dietéticas de Referencia (IDR) para la Población Española.
Act Diet, 14 (2010), pp. 196-197
F. dos Santos, M.M. de, M.C. Borges, M.I.T.D. Correia, R.W. Telles, C.C.D. Lanna.
Assessment of nutritional status and physical activity in systemic lupus erythematosus patients.
Rev Bras Reumatol, 50 (2010), pp. 631-645
M.C. Borges, F.D.M.M. dos Santos, R.W. Telles, C.C.D. Lanna, M.I.T.D. Correia.
Nutritional status and food intake in patients with systemic lupus erythematosus.
Nutrition, 28 (2012), pp. 1098-1103
D.M. Rocha, J. Bressan, H.H. Hermsdorff.
The role of dietary fatty acid intake in inflammatory gene expression: a critical review.
Sao Paulo Med J, (2017),
Y. Ma, J.R. Hébert, W. Li, E.R. Bertone-Johnson, B. Olendzki, S.L. Pagoto, et al.
Association between dietary fiber and markers of systemic inflammation in the Women's Health Initiative Observational Study.
Nutrition, 24 (2008), pp. 941-949
Y. Ma, J.A. Griffith, L. Chasan-Taber, B.C. Olendzki, E. Jackson, E.J. Stanek, et al.
Association between dietary fiber and serum C-reactive protein.
Am J Clin Nutr, 83 (2006), pp. 760-766
A. Oeser, C.P. Chung, Y. Asanuma, I. Avalos, C.M. Stein.
Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus.
Arthritis Rheum, 52 (2005), pp. 3651-3659
A. Rizk, T.A. Gheita, S. Nassef, A. Abdallah.
The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis.
Int J Rheum Dis, 15 (2012), pp. 261-267
V. Bellomio, A. Spindler, E. Lucero, A. Berman, R. Sueldo, H. Berman, et al.
Metabolic syndrome in Argentinean patients with systemic lupus erythematosus.
Lupus, 18 (2009), pp. 1019-1025
A. Mazur, J.A.M. Maier, E. Rock, E. Gueux, W. Nowacki, Y. Rayssiguier.
Magnesium and the inflammatory response: potential physiopathological implications.
Arch Biochem Biophys, 458 (2007), pp. 48-56
P. Gisondi, F. Fantuzzi, M. Malerba, G. Girolomoni.
Folic acid in general medicine and dermatology.
J Dermatolog Treat, 18 (2007), pp. 138-146
J. Selhub, P.F. Jacques, I.H. Rosenberg, G. Rogers, B.a Bowman, E.W. Gunter, et al.
Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991–1994): population reference ranges and contribution of vitamin status to high serum concentrations.
Ann Intern Med, 131 (1999), pp. 331-339
C. Lourdudoss, A.-C. Elkan, I. Hafstro, T. Jogestrand, T. Gustafsson, R. Van Vollenhoven, et al.
Dietary micronutrient intake and atherosclerosis in systemic lupus erythematosus.
Lupus, 0 (2016), pp. 1-8
B. Debreceni, L. Debreceni.
The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease.
Cardiovasc Ther, 32 (2014), pp. 130-138
E. Maeshima, X.M. Liang, M. Goda, H. Otani, M. Mune.
The efficacy of vitamin E against oxidative damage and autoantibody production in systemic lupus erythematosus: a preliminary study.
Clin Rheumatol, 26 (2007), pp. 401-404
Copyright © 2018. SEEN y SED
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos